Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression

Journal of the American Society of Nephrology

Volumn 14, Issue 9, 2003, Pages 2358-2365

  Abbott, Kevin C ^a,b   Yuan, Christina M ^a,b   Taylor, Allen J ^a   Cruess, David F ^b   Agodoa, Lawrence Y C ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0042821638     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000083008.25305.67     Document Type: Article

References (46)

1. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP: Post-transplant renal function in the first 1 yr predicts long-term kidney transplant survival. Kidney Int 62: 311-318, 2002
2. Bostom AD, Brown RS Jr, Chavers BM, Coffman TM, Cosio FG, Culver K, Curtis JJ, Danovitch GM, Everson GT, First MR, Garvey C, Grimm R, Hertz MI, Hricik DE, Hunsicker LG, Ibrahim H, Kasiske BL, Kennedy M, Klag M, Knatterud ME, Kobashigawa J, Lake JR, Light JA, Matas AJ, McDiarmid SV, Miller LW, Payne WD, Rosenson R, Sutherland DE, Tejani A, Textor S, Valantine HA, Wiesner RH: Prevention of post-transplant cardiovascular disease: Report and recommendations of an ad hoc group. Am J Transplant 2: 491-500, 2002
3. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
4. Garg AX, Clark WF, Haynes RB, House AA: Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney Int 61: 1486-1494, 2002
5. Hypolite IO, Bucci J, Hshieh P, Cruess D, Agodoa LY, Yuan CM, Taylor AJ, Abbott KC: Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes mellitus. Am J Transplant 2: 274-281, 2002
6. Abbott KC, Bucci JR, Cruess D, Taylor AJ, Agodoa LY: Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol 13: 2560-2569, 2002
7. Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J: Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13: 1084-1090, 2002
8. Ducloux D, Motte G, Challier B, Gibey R, Chalopin JM: Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: A prospective study. J Am Soc Nephrol 11: 134-137, 2000
9. Keunecke C, Rothenpieler U, Zanker B, Schneeberger H, Illner WD, Theodorakis J, Stangl M, Land W: Mycophenolate mofetil monotherapy: An example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients. Transplant Proc 2[Suppl]: 6S-8S, 2000
10. Galiatsou E, Morris ST, Jardine AG, Rodger RS, Watson MA, Elliott HL: Cardiac and vascular abnormalities in renal transplant patients: Differential effects of cyclosporin and azathioprine. J Nephrol 13: 185-192, 2000
11. Montagnino G, Tarantino A, Segoloni GP, Cambi V, Rizzo G, Altieri P, Castagneto M, Salvadori M, Cossu M, Pisani F, Carmellini M, Mastrangelo F, Ferrara R, Ponticelli C: Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation. J Am Soc Nephrol 12: 2163-2169, 2001
12. Shaheen FA, Souqiyyeh MZ, Shiek IA, Fedhail H, al-Sulaiman M, Mousa D, al-Hawas F, al-Khader AA: Hypercholesterolemia in renal transplantation. Ann Transplant 6: 9-13, 2001
13. Curtis JJ: Treatment of hypertension in renal allograft patients: Does drug selection make a difference? Kidney Int Suppl 63: S75-S77, 1997
14. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC: Association of hepatitis C with posttransplant diabetes mellitus in renal transplant patients on tacrolimus. J Am Soc Nephrol 13: 1374-1380, 2002
15. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178-185, 2003
16. Kasiske BL, Chakkera HA, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11: 1735-1743, 2000
17. Margreiter R: Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study. Lancet 359: 741-746, 2002
18. Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR: Validation of comorbid conditions on the end-stage kidney disease medical evidence report: The CHOICE study: Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11: 520-529, 2000
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
20. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman AB, Cibrik D, Magee JC, Wolfe RA, Agodoa LY, Kaplan B: Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69: 2405-2409, 2000
21. Szklo M, Nieto FJ: Epidemiology: Beyond the Basics, Gaithersburg, MD, Aspen Publishers, 2000, p 257
22. SPSS: SPSS 9.0 Advanced Models: Application Guide, Chicago, SPSS Inc., 1999
23. Kleinbaum DG: Survival Analysis: A Self-Learning Text (Statistics in the Health Sciences), New York, Springer Verlag, 1996
24. http://www.usrds.org, accessed March 5, 2003
25. http://www.kidney.org/professionals/doqi/kdoqi/p4_class_gl.htm, accessed March 7, 2003
26. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102: 203-210, 2000
27. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG: Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14: 415-424, 2003
28. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
29. Ritz E, Dikow R, Ruilope LM: Renal dysfunction as a cardiovascular risk factor. Curr Hypertens Rep 4: 365-368, 2002
30. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R: Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol 13: 1928-1936, 2002
31. Walsh CR, O'Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM: Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 144: 1003-1011, 2002
32. Meier-Kriesche HU, Baliga R, Kaplan B: Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 75: 1291-1295, 2003
33. Ducloux D, Challier B, Saas P, Tiberghien P, Chalopin JM: CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol 14: 767-772, 2003
34. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555-562, 2002
35. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 137: 563-570, 2002
36. Tonelli M, Moye L, Sacks FM, Kiberd B, Curhan G: Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med 138: 98-104, 2003
37. Seliger SL, Weiss NS, Gillen DL, Kestenbaum B, Ball A, Sherrard DJ, Stehman-Breen CO: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61: 297-304, 2002
38. Trespalacios FC, Taylor AJ, Agodoa LY, Abbott KC: Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 62: 1799-1805, 2002
39. Herzog CA, Ma JZ, Collins AJ: Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Aro Ain J Kidney Dis 36: 145-152, 2000
40. Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B: Survival improvement among patients with end-stage renal disease: Trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 12: 1293-1296, 2001
41. Abbott KC, Hypolite IO, Hshieh P, Cruess D, Taylor AJ, Agodoa LY: Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol 12: 115-122, 2002
42. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P: Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14: 462-468, 2003
43. Helderman JH, Bennett WM, Cibrik DM, Kaufman DB, Klein A, Takemoto SK: Immunosuppression: Practice and trends. Am J Transplant 3[Suppl 4]: 41-52, 2003
44. Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL: Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41: 360-370, 2003
45. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002
46. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342: 605-612, 2000